CD117 Expression in Dog Mast Cell Tumors
Author Information
Author(s): Gil da Costa Rui M, Matos Eduarda, Rema Alexandra, Lopes Célia, Pires Maria A, Gärtner Fátima
Primary Institution: Instituto de Ciências Biomédicas de Abel Salazar (ICBAS), University of Porto, Porto, Portugal
Hypothesis
This study addresses the role of CD117 in canine mast cell tumours by studying the correlations between CD117 immunoexpression patterns, two proliferation markers (Ki67 and AgNORs), histological grade, and several other pathological variables.
Conclusion
The study confirms that aberrant CD117 expression is related to increased cell proliferation and higher histological grade in canine mast cell tumors.
Supporting Evidence
- Highly significant correlations were found between CD117 immunostaining patterns and histological grade.
- Cytoplasmic CD117 expression correlates with higher histological grade and increased cell proliferation.
- A significant correlation was observed between CD117 expression patterns and epidermal ulceration.
Takeaway
This study found that a specific protein called CD117 is important in understanding how aggressive certain tumors are in dogs.
Methodology
The study analyzed 103 mast cell tumors from 67 dogs, examining CD117 expression patterns and correlating them with histological grading and proliferation markers.
Limitations
The study did not find significant correlations between the breed of the animals and any other variables studied.
Participant Demographics
The study included 67 dogs, comprising 30 males and 37 females, with ages ranging from 2 to 20 years, and a mean age of 7.3 years.
Statistical Information
P-Value
0.035
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website